Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

hematologic · Mechanism Report

Can TMPRSS6 and HFE variants together cause discordant iron studies?

TMPRSS6 and HFE variants can push iron regulation in opposite directions and produce high transferrin saturation with low ferritin.

PlausibleJuly 14, 202617 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Opposing hepcidin-related tendencies from TMPRSS6 and HFE variants can produce discordant iron studies when combined with transient serum iron elevation and depleted ferritin stores.

laying out figure…
3 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says opposing hepcidin-related effects from TMPRSS6 and HFE variants can disrupt the usual pattern of iron markers. TMPRSS6 tends to raise hepcidin and limit iron stores, while HFE tends to lower hepcidin and favor iron loading; a transient rise in serum iron can further accentuate the mismatch between saturation and ferritin.

Verified conclusion

Genetic variations in hepatic iron-sensing pathways can exert opposing physiological forces, disrupting the typical diagnostic patterns of systemic iron status.

Molecular mechanisms of opposing hepcidin signaling

  • TMPRSS6-mediated restriction: The TMPRSS6 gene encodes matriptase-2, which cleaves membrane hemojuvelin to downregulate BMP/SMAD signaling. Hypofunctional variants (such as rs4820268 GG or rs855791) result in inappropriately elevated hepcidin levels, which restricts intestinal iron absorption and leads to depleted ferritin stores.
  • HFE-mediated loading: Pathogenic HFE variants (such as C282Y or H63D) disrupt the hepatic iron-sensing complex, suppressing hepcidin relative to body iron stores to promote permissive intestinal iron absorption and elevate transferrin saturation.
  • Genetic epistatic interactions: Evidence from mouse double-knockout models and human patient cohorts demonstrates that TMPRSS6 variants can override or modulate the low-hepcidin signal and iron-loading phenotype typically driven by HFE deficiency.

Clinical implications of discordant iron panels

  • Phenotypic discordance: The coexistence of these genetic variants pulls iron indicators in opposite directions. The TMPRSS6 variant drives lower ferritin levels and depleted tissue stores, while the HFE variant maintains elevated transferrin saturation.
  • Superimposed transient spikes: When transient serum iron spikes—driven by diurnal fluctuations, dietary intake, or the timing of blood draws—are superimposed on these chronically depleted ferritin stores, it creates a highly discordant clinical picture of elevated transferrin saturation paired with low ferritin.

Bottom line

  • Coexisting TMPRSS6 and HFE variants disrupt classic clinical profiles, producing discordant iron panels of high transferrin saturation alongside depleted ferritin stores when accompanied by transient serum iron spikes.

References

  1. TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis — link.springer.com ↗
  2. Mutations in TMPRSS6 cause iron-refractory iron deficiency ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. The role of TMPRSS6/matriptase-2 in iron regulation and anemia — pmc.ncbi.nlm.nih.gov ↗
  4. A genome-wide association analysis of serum iron concentrations — ncbi.nlm.nih.gov ↗
  5. The association of TMPRSS6 gene polymorphism with iron status in ... — pmc.ncbi.nlm.nih.gov ↗
  6. Frontiers | The role of TMPRSS6/matriptase-2 in iron regulation and anemia — frontiersin.org ↗
  7. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume — ncbi.nlm.nih.gov ↗
  8. Tmprss6 is a genetic modifier of the Hfe-hemochromatosis ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  9. Iron overload — uomustansiriyah.edu.iq ↗
  10. Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment. — linkinghub.elsevier.com ↗
  11. Diagnosis and Treatment of Genetic HFE-Hemochromatosis - PMC — pmc.ncbi.nlm.nih.gov ↗
  12. Effects of C282Y, H63D, and S65C HFE gene mutations, diet ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  13. The Association of TMPRSS6 Gene Polymorphism and Iron ... — pmc.ncbi.nlm.nih.gov ↗
  14. The association of TMPRSS6 gene polymorphism with iron status in Egyptian children (a pilot study) — bmcpediatr.biomedcentral.com ↗
  15. Iron Indices — haematologica.org ↗
  16. Transferrin Saturation/Hepcidin Ratio Discriminates TMPRSS6 ... — pmc.ncbi.nlm.nih.gov ↗
  17. The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis — bmcnephrol.biomedcentral.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible9 sourcesCan zinc influence thyroid hormone synthesis and metabolism, and can vitamin B12 or folate deficiency raise mean corpuscular volume?→Plausible4 sourcesCan high bilirubin with a low red blood cell count suggest increased heme turnover?→